RxDoctor Payments Data

John Hutto, MD

Vascular Surgery · Green Bay, WINPI 1972714285

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (54.4%), food and beverage and education — rather than concentrated in one kind of arrangement. W. L. Gore & Associates, Inc. accounts for 63.1% of it on its own, with 10 other manufacturers making up the rest.

$3,769in general payments, 2019–2025

Across 39 payments — averaging $96.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$2K
  • Integra Lifesciences Corporation$1K
  • KCI USA, Inc.$112
  • Boehringer Ingelheim$43
  • Johnson & Johnson$35
  • Silk Road Medical, Inc.$35
  • plus $108 from 5 others
$7,025in research payments, 2019–2025

Across 4 payments — averaging $1756.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bard Peripheral Vascular, Inc.$7K

What the payments were for

  • Travel & lodging$2,04954%
  • Food & beverage$1,53941%
  • Education$1805%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,769 in reported general payments places this provider in the 65th percentile of 81 vascular surgery providers in Wisconsin.

See all vascular surgery providers in Wisconsin

Medicare billing

Part B allowed, 2024
$102,759
Medicare patients
347
Services billed
618

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate116$1,170
Cilostazol17$413
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen29$172

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Green Bay

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →